Use of a Dermatology-Specific Discharge Form to Improve Outpatient Follow-up after Inpatient Dermatology Consultation

Use of a Dermatology-Specific Discharge Form to Improve Outpatient Follow-up after Inpatient Dermatology Consultation

Journal Pre-proof Use of a Dermatology-Specific Discharge Form to Improve Outpatient Follow-up after Inpatient Dermatology Consultation Alyssa Miceli,...

174KB Sizes 0 Downloads 17 Views

Journal Pre-proof Use of a Dermatology-Specific Discharge Form to Improve Outpatient Follow-up after Inpatient Dermatology Consultation Alyssa Miceli, DO, Karthik Krishnamurthy, DO PII:

S0190-9622(20)30141-9

DOI:

https://doi.org/10.1016/j.jaad.2020.01.057

Reference:

YMJD 14190

To appear in:

Journal of the American Academy of Dermatology

Received Date: 16 May 2019 Revised Date:

5 January 2020

Accepted Date: 11 January 2020

Please cite this article as: Miceli A, Krishnamurthy K, Use of a Dermatology-Specific Discharge Form to Improve Outpatient Follow-up after Inpatient Dermatology Consultation, Journal of the American Academy of Dermatology (2020), doi: https://doi.org/10.1016/j.jaad.2020.01.057. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2020 Published by Elsevier on behalf of the American Academy of Dermatology, Inc.

1

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36

Article type: Research Letter Title: Use of a Dermatology-Specific Discharge Form to Improve Outpatient Follow-up after Inpatient Dermatology Consultation Alyssa Miceli, DO1, Karthik Krishnamurthy, DO1 1

Orange Park Medical Center, 906 Park Avenue, Orange Park, FL 32073

Corresponding author: Alyssa Miceli, DO 906 Park Avenue Orange Park, FL 32073 Email: [email protected] Funding sources: American Academy of Dermatology’s Patient Safety and Quality Committee Resident and Fellow Quality Improvement Project Award Conflicts of Interest: None declared. Prior Presentation: Preliminary data presented at the American Academy of Dermatology 2017 Annual Meeting, Orlando, FL. Reprint requests: Alyssa Miceli, DO Manuscript word count: 550 words [excluding references, figures, and tables] Capsule summary word count: N/A References: 4 Figures: 0 Tables: 2 Supplementary Figures: 1 (DOI: 10.17632/hdwswgb23g.2) Attachments: Submission Checklist Keywords: quality improvement; consultations; dermatology; continuity of care; discharge form; outpatient follow-up

2

37

Inpatient dermatology consultations have been shown to be associated with decreased 1-year

38

readmission rates for patients with inflammatory skin conditions.1 We anecdotally identified non-

39

compliance with post-discharge follow-up appointments with consulting dermatologists as a cause of

40

poor outcomes among patients hospitalized for inflammatory skin conditions. To address this area of

41

unmet need, we performed a resident-led quality-improvement project that assessed the effect of

42

implementing a dermatology-specific discharge form on compliance with post-discharge dermatology

43

appointments.

44

Dermatology consult patients who were previously noncompliant with post-discharge

45

appointments were contacted via telephone to identify barriers to follow-up. Some reasons reported

46

included lack of understanding of their inpatient skin diagnoses and the need for long-term outpatient

47

management, discontinuation of the inpatient dermatologic treatment regimen upon discharge, and

48

confusion about how and where to follow-up. Many patients believed that they only needed to follow-up

49

with their primary care physician, suggesting suboptimal communication regarding dermatologic care

50

upon hospital discharge.

51

A dermatology-specific discharge form was developed based on these responses, which was to be

52

completed by the consulting dermatologist and included with the hospital discharge summary. The form

53

was designed to educate consult patients about their dermatologic condition(s) and treatment plan and

54

provide detailed follow-up instructions.

55

The dermatology-specific discharge form was given to 53 consult patients upon discharge in

56

2017. Follow-up appointments were made prior to discharge in reserved slots on the consult resident’s

57

continuity clinic schedule and the appointment information was included on the discharge form. 47

58

consult patients prior to the implementation of the dermatology-specific discharge form were used as

59

historical controls. All patients included were otherwise given the hospital’s standard discharge summary.

60

Follow-up appointment-keeping compliance rates were compared over the 1-year periods before and after

61

the implementation.

3

62

Of the 100 consults included, 57.0% were female with a mean (SD) age of 63.3 (19.7) years. In

63

line with previous studies,2,3 our consultations had a significant impact on the inpatient management of

64

skin conditions, changing the diagnosis and treatment plan in 69% and 83% of cases, respectively (Table

65

1). Multivariate regression analysis showed that patients given the dermatology-specific discharge form

66

were more likely to follow-up compared with consult patients prior to this implementation (60.4% vs.

67

21.2%, RR 2.25; 95% CI 1.18-4.28; p=0.004). Patients with an acute flare of a chronic condition (as

68

compared to an acute new condition) were also more likely to follow-up (RR 2.11; p=0.003), while there

69

was no statistically significant difference in follow-up rates based on age or gender (Table 2).

70

Improved outpatient follow-up compliance rates with use of a dermatology-specific discharge

71

form may be due to improved accuracy and specificity of dermatology information provided to patients

72

upon discharge. One possible contributing factor is that the form is designed to be completed by the

73

consulting dermatologist, as one study found that the accuracy rate of dermatology documentation in

74

hospital discharge summaries completed by nondermatologists was only 54.5%.4

75

The study is limited by its retrospective nature and generalizability given the implementation at a

76

single community based academic medical center. Though patients in the intervention group had reduced

77

all-cause 30-day hospital readmission rates (6.9% vs. 9.2%, p=0.03), it is beyond the scope of this study

78

to correlate this with the higher rates of clinic follow-up. Future studies evaluating use of a dermatology-

79

specific discharge form as a mechanism for reducing readmission rates of inflammatory skin conditions

80

are warranted.

81 82 83 84 85

4

86

References

87

1. Milani-Nejad N, Zhang M, Kaffenberger BH. Association of dermatology consultations with patient

88

care outcomes in hospitalized patients with inflammatory skin diseases. JAMA Dermatol.

89

2017;153(6):523-528.

90

2. Hu L, Haynes H, Ferrazza D, et al. Impact of specialist consultations on inpatient admissions for

91

dermatology-specific and related DRGs. J Gen Intern Med. 2013; 28(11):1477-1482.

92

3. Kroshinsky D, Cotliar J, Hughey LC, et al. Association of dermatology consultation with accuracy of

93

cutaneous disorder diagnoses in hospitalized patients: A multicenter analysis. JAMA Dermatol.

94

2016;152(4):477-480.

95

4. Zhao C, Ang R, George R, et al. The quality of dermatology consultation documentation in discharge

96

summaries: a retrospective analysis. Int J Womens Dermatol. 2016;2(1):23-27.

97 98 99 100 101

Table 1. Impact of Dermatologic Consultations on Diagnoses and Management

Consults (N=100)

Final Diagnosis n (%)

Change from Original Diagnosis

Change in Management

Blistering Disorder

6 (6)

6/6

6/6

Drug Eruption

24 (24)

18/24

20/24

Psoriasis

8 (8)

5/8

7/8

Dermatitis*

21 (21)

15/21

18/21

Cutaneous Malignancy

9 (9)

4/9

9/9

Fungal infection

4 (4)

4/4

4/4

Cellulitis

7 (7)

1/7

2/7

5

Vasculitis

4 (4)

3/4

4/4

Furunculosis

4 (4)

2/4

3/4

Connective Tissue Disease

3 (3)

3/3

2/3

Viral Exanthem

10 (10)

8/10

8/10

69/100 (69%)

83/100 (83%)

102

*Dermatitis including: eczematous dermatitis, contact dermatitis, stasis dermatitis, seborrheic dermatitis

103 104

Table 2. Demographic and Intervention Factors and Follow-up Appointment Success Rates

105 Subgroup

No.a

Completed Follow-up RR (95% CI)

P value

n (%) Sex Female

57

27 (47.3)

1.38 (0.76-2.49)

0.29

Male

43

14 (32.6)

1

Ref

≥65

59

24 (40.6)

1.32 (0.64-2.47)

0.12

<65

41

15 (36.6)

1

Ref

Yes

53

32 (60.4)

2.25 (1.18-4.28) b 0.004

No

47

10 (21.1)

1

Ref

Acute on Chronic

30

18 (60)

2.11 (1.29-3.46)

0.003

Acute

70

22 (31.4)

1

Ref

Age

Dermatology Consult Discharge Form

Condition

106

RR, Risk Ratio; CI, Confidence interval

107

a

108

b

109

Total consults (N=100) Log-binomial regression model after adjustment for age and sex